The U.S. Supreme Court let federal funding continue for human embryonic stem-cell research, turning away an appeal that accused the Obama administration of skirting federal law.
Former brokers of Bank of America Corp.’s Merrill Lynch & Co. unit asked a federal judge to approve a $40 million settlement in a lawsuit over deferred compensation.
A lawsuit challenging U.S. funding for human embryonic stem-cell research was rejected by a federal appeals court in Washington, which upheld a lower court’s ruling dismissing the case.
U.S. funding of human embryonic stem-cell studies can continue while a lower court decides whether the government-backed research violates the law, a federal appeals court said.
A challenge to the funding of human embryonic stem-cell studies was dismissed by a federal judge after an appeals court found the government-backed research is probably lawful.
A challenge to funding of human embryonic stem-cell studies should be dismissed after an appeals court found the government-backed research to be lawful, the Obama administration said.
Opponents of human embryonic stem- cell research asked a federal appeals court to reverse a judge’s ruling that the U.S. may continue to fund experiments in the field.
Research using human embryonic stem- cell lines approved under President Barack Obama is accelerating, boosting a scientific field that’s been dogged by legal and political threats.
The Obama administration can’t continue to fund embryonic stem-cell research while appealing a ban on government support for any activity using cells taken from human embryos, a federal judge ruled.
Federal funding for embryonic stem cell studies in the U.S. is again under attack after a judge blocked President Barack Obama ’s expanded rules for scientists, potentially disrupting the field and discouraging new research.